Leonard Frank X - Sep 2, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Development Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
Stock symbol: NVCR
Transactions as of: Sep 2, 2021
Transactions value $: -$74,645
Form type: 4
Date filed: 9/7/2021, 04:39 PM
Previous filing: Aug 4, 2021
Next filing: Mar 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	-$74.6K	-540	-0.62%	$138.23	87.2K	Sep 2, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Amended total to correct prior mathematical error.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Amended total to correct prior mathematical error.